Demand for Nutraceuticals in Singapore

Nutraceuticals demand in Singapore is anticipated to expand from USD 4.9 billion in 2026 to USD 12.2 billion by 2036, registering a CAGR of 9.6%. Functional food is expected to hold a dominant 44.0% share by product type, while immunity applications will lead with a 48.0% share. Preventive positioning is projected to account for 55.0% of functionality-led demand, tablets and capsules will remain the leading form at 42.2%, and clean label claims will lead with a 56.6% share.